Filing Flows › Coya Therapeutics (COYA) › Q1 2026 › vs Q1 2025
Coya Therapeutics (COYA) Q1 2026 vs Q1 2025 (year over year)
Coya Therapeutics's revenue fell $7K (-3%) from $258K in Q1 2025 to $251K in Q1 2026.
Coya Therapeutics, Q1 2026: revenue $251K (-3% year over year), net loss $7.2M, operating cash flow −$6.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $251K | $258K | −$7K | -3% |
| Other income, net | $433K | $370K | $63K | +17% |
| Net loss | $7.2M | $7.3M | −$100K | -1% |
| Costs & expenses | $7.9M | $7.9M | −$43K | -0.5% |
| Operating costs | $7.9M | $7.9M | −$43K | -0.5% |
| Research & development | $4.1M | $5.2M | −$1.1M | -21% |
| General & admin | $3.8M | $2.7M | $1.1M | +39% |
| Operating cash sources | $8.4M | $3.9M | $4.5M | +115% |
| Depreciation | $3K | $7K | −$4K | -59% |
| Share-based compensation | $2.2M | $1.1M | $1.1M | +103% |
| Cash used in operations | $6.2M | $2.8M | $3.4M | +120% |
| Net loss absorbed | $7.2M | $7.3M | −$100K | -1% |
| Working capital & other | $1.2M | −$3.4M | $4.6M | — |
Questions
How much did Coya Therapeutics's revenue grow year over year in Q1 2026?
Coya Therapeutics's revenue fell $7K (-3%) from $258K in Q1 2025 to $251K in Q1 2026.